High-dose pulsed hyaluronidase protocol explained
Why emergency reversal uses repeated high doses rather than a single injection, and what the published protocols and case reports actually describe.
The high-dose pulsed protocol is the standard published approach to hyaluronic acid vascular occlusion, and it differs from elective dissolution in almost every parameter.
The reasoning
An occluding plug of filler sits inside a vessel. To be dissolved it must be reached by enzyme, and the enzyme has to be present in sufficient concentration for long enough. A single injection produces a brief peak that decays quickly — often before the plug has been meaningfully degraded.
Pulsing maintains exposure. Repeated administration at intervals keeps enzyme concentration in the affected territory elevated across the period needed, rather than delivering one dose that has largely gone before it has worked.
What the protocols specify
Published guidance describes reconstitution at around 1500 units per 1 mL and flooding the whole ischaemic territory rather than injecting at the entry point. Administration is repeated at intervals and continued until perfusion returns.
The reported totals are large by the standards of elective practice. Case reports describe courses totalling several thousand units over hours, and in one published forehead case a cumulative 32,000 units across four days, with complete epithelialisation by day 30 and near-complete recovery by day 90 without scarring. Another describes 2,850 IU over a fifteen-hour period alongside aspirin, warm compresses and gentle massage, with full recovery by day 21.
The number is not the target. The endpoint is clinical — capillary refill, colour, resolution of mottling — and dosing continues until it is reached.
Territory, not site
The instruction that most often gets lost: inject where the ischaemia is, across its whole extent, and not merely where the needle originally went in. Embolised product sits along the vessel, potentially some distance downstream from the entry point.
Late presentation
The most encouraging finding in the recent case literature is that delayed intervention has still produced good outcomes. A published forehead case treated well outside the conventional window recovered fully. Whatever the theoretical time limits, the clinical inference is unambiguous: start immediately regardless of how much time has passed.
What the protocol does not cover
Retinal occlusion is a different problem. Once the central retinal artery is involved, the window is roughly 60 to 90 minutes and management is an ophthalmic emergency — retrobulbar hyaluronidase has been described and has an anatomical guideline, but it is a specialist procedure and the referral should be moving while it is being considered.
Non-hyaluronic-acid fillers have no equivalent protocol, because they have no antidote.
